CLINICAL_TRIALS
trial_result
· 2014-07-18
Clinical Trial Update: Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain [Phase 3]
Summary
A Phase 3 trial of eslicarbazepine acetate for painful diabetic neuropathy was terminated, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Painful Diabetic Neuropathy | Phase 3 | Status: TERMINATED | Results posted: 2014-07-18